1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL01, NCT00198991
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: EORTC-58951, NCT00003728
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: COG-AALL0232, NCT00075725, AALL0232
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 10
Sponsor: NCI
Protocol IDs: COG-AALL0331, AALL0331, NCT00103285
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: AMLCG 99, BMBF 01 GI 02070, NCT00266136
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 4 at diagnosis
Sponsor: NCI
Protocol IDs: COG-AAML0431, AAML0431, NCT00369317
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: COG-AALL0434, AALL0434, NCT00408005
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: ALL-BFM-2000, EU-20682, NCT00430118
|
|
11.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ID03-0124, NCT00452439
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: TOTXVI, NCT00549848
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: MOTOL-ALL-IC-BFM-2002, ALL-IC-BFM-2002, EU-20871, NCT00764907
|
|
14.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 20 and under
Sponsor: Other
Protocol IDs: T2005-001, NCT00439296
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 64
Sponsor: NCI
Protocol IDs: SWOG-S0333, S0333, NCT00109837
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 55
Sponsor: Other
Protocol IDs: 9L-03-1, NCT00184041
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 and over
Sponsor: Other
Protocol IDs: 2003-0600, NCT00504660
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 16 to 30
Sponsor: NCI
Protocol IDs: CALGB-10403, CALGB 10403, ECOG C10403, SWOG C10403, NCT00558519
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 to 40
Sponsor: Other
Protocol IDs: 2006-0375, NCT00866749
|
|
20.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: GER-COALL-07-03, EU-205104, NCT00343369
|
|
21.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 365 days and under
Sponsor: Other
Protocol IDs: DCOG-INTERFANT-06, DCOG-INTERFANT-06, EUDRACT-2005-004599-19, NCT00550992, CCLG-LK-2006-10
|
|
22.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: COG-AALL07P4, AALL07P4, NCT00671034
|
|
23.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: Child
Sponsor: Other
Protocol IDs: POWH-CRE-2008.077-T, CRE-2008.077-T, NCT00707083
|
|
24.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 30 at diagnosis
Sponsor: NCI
Protocol IDs: COG-AALL08P1, AALL08P1, NCT00866307
|
